- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01571440
Soluble Corn Fiber and Calcium Utilization in Adolescents
February 7, 2014 updated by: Berdine Martin, Purdue University
The Effect of Soluble Corn Fiber on Calcium Utilization and Retention and Gut Microflora in Adolescents
The purpose of this study was to determine the effect of soluble corn fiber on calcium absorption and retention and gut microflora in adolescent boys and girls.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In a previous study, soluble corn fiber (SCF) was found to greatly enhance calcium utilization and bone properties in a growing rat model.
Because factors that enhance bone density and mineral content can potentially result in a skeleton that will resist fracture later in life, it is important to investigate this potential in adolescents.
Therefore, the objective of this study was to determine the effect of SCF on calcium absorption and retention in adolescent boys and girls.
A second objective of this study was to assess whether additional dietary fiber leads to changes in gut microflora which may influence calcium absorption.
During this two-phase metabolic camp participants consumed packages of fruit snacks supplemented with either 0 or 6 grams of soluble corn fiber twice a day during the first phase of the study, and switch to the opposite treatment during the second phase, with a 2-week washout period in between.
Subjects collected all excreta during both phases and calcium absorption, gut microbiota, height, weight, and bone density were evaluated throughout the 6-week period of the study.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 15 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal, healthy, white adolescents (Hispanic or non-Hispanic)
- Boys age 13-15
- Girls age 12-14
Exclusion Criteria:
- Abnormal kidney or liver function
- Malabsorptive disorders
- Anemia
- Smoking
- History of medications that affect calcium metabolism
- Body weight outside 5-95 percentile body mass index (BMI) for age
- Regular consumption of illegal drugs
- Contraceptive use
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: No Soluble Corn Fiber
Each teen will receive a package of fruit snacks containing 0 g soluble corn fiber two times daily.
|
Each teen will receive a package of fruit snacks containing 0 g soluble corn fiber two times per day
Other Names:
|
|
Active Comparator: 12 g Soluble Corn Fiber
Each teen will receive a package of fruit snacks containing 6 g soluble corn fiber two times daily
|
Each teen will receive a package of fruit snacks containing 6 g soluble corn fiber two times per day.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Calcium absorption and retention
Time Frame: up to three weeks
|
up to three weeks
|
|
Gut microbial profile
Time Frame: up to three weeks
|
up to three weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Bone mineral content and density
Time Frame: up to three weeks
|
up to three weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Connie Weaver, PhD, Purdue University
- Study Director: Berdine Martin, PhD, Purdue University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
July 1, 2010
Study Completion (Actual)
July 1, 2010
Study Registration Dates
First Submitted
January 12, 2011
First Submitted That Met QC Criteria
April 4, 2012
First Posted (Estimate)
April 5, 2012
Study Record Updates
Last Update Posted (Estimate)
February 10, 2014
Last Update Submitted That Met QC Criteria
February 7, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Camp Calcium 11-Tate and Lyle
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
AmgenCompletedPost Menopausal OsteoporosisFrance
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisSpain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
Clinical Trials on No soluble corn fiber
-
Phoenix Children's HospitalMayo Clinic; Northern Arizona University; Flinn FoundationCompleted
-
University of Illinois at Urbana-ChampaignTate and Lyle Ingredients Americas LLCRecruiting
-
JeyaKumar HenryTate and Lyle Ingredients FranceCompletedObesity | Pre DiabetesSingapore
-
Purdue UniversityTate & Lyle Health & Nutrition SciencesCompletedOsteoporosis, Postmenopausal
-
University of MinnesotaTate and Lyle Ingredients FranceCompleted
-
VA Office of Research and DevelopmentSan Francisco VA Health Care SystemRecruiting
-
University of Illinois at Urbana-ChampaignCompleted
-
Tate & LyleBiofortis Innovation ServicesCompletedGastrointestinal ToleranceUnited States